Company logo

ACOR - Acorda Therapeutics, Inc.

NASDAQ -> Healthcare -> Biotechnology
Ardsley, United States

ACOR price evolution
ACOR
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Current assets
Cash $51.45 $65.22 $61.92 $71
Short term investments
Net receivables $11.99 $17 $13.59 $14.01
Inventory $14.84 $18.55 $20.59 $25.36
Total current assets $80.45 $102.16 $97.07 $112.94
Long term investments
Property, plant & equipment $9.26 $11.13 $12.88 $14.66
Goodwill & intangible assets $328.23 $335.98 $343.73 $351.48
Total noncurrent assets $343.68 $353.31 $369.02 $378.56
Total investments
Total assets $424.14 $455.47 $466.09 $491.5
Current liabilities
Accounts payable $8.77 $10.85 $15.5 $17.48
Deferred revenue
Short long term debt $7.04 $8.19 $9.32 $10.71
Total current liabilities $46 $54.02 $68.27 $67.66
Long term debt $186.31 $182.76 $179.66 $176.37
Total noncurrent liabilities $250.59 $250.31 $233.34 $233.36
Total debt $193.34 $190.94 $188.98 $187.07
Total liabilities $296.59 $304.33 $301.61 $301.02
Shareholders' equity
Retained earnings -$894.88 -$870.36 -$849.79 -$822.72
Other shareholder equity -$0.57 -$1.02 -$1.56 -$1.83
Total shareholder equity $127.55 $151.14 $164.47 $190.48
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $65.22 $102.89 $105.19 $294.1
Short term investments $63.75 $151.99
Net receivables $17 $20.19 $22.08 $23.43
Inventory $18.55 $28.68 $25.22 $29.01
Total current assets $102.16 $221.34 $201.11 $528.11
Long term investments
Property, plant & equipment $11.13 $25.74 $165.98 $60.52
Goodwill & intangible assets $335.98 $366.98 $402.33 $710.63
Total noncurrent assets $353.31 $411.35 $598.61 $771.56
Total investments $63.75 $151.99
Total assets $455.47 $632.68 $799.72 $1299.67
Current liabilities
Accounts payable $10.85 $12.15 $26.26 $48.86
Deferred revenue
Short long term debt $8.19 $76.58 $8.35 $0.62
Total current liabilities $54.02 $137.25 $86.39 $140.26
Long term debt $182.76 $183.37 $241.26 $343.14
Total noncurrent liabilities $250.31 $257.47 $402.51 $547.43
Total debt $190.94 $259.95 $249.61 $343.76
Total liabilities $304.33 $394.73 $488.9 $687.68
Shareholders' equity
Retained earnings -$870.36 -$766.4 -$666.81 -$393.84
Other shareholder equity -$1.02 -$2.8 -$1.17 $2.81
Total shareholder equity $151.14 $237.96 $310.82 $611.98
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Revenue
Total revenue $22.53 $36.97 $31.46 $31.79
Cost of revenue $5.97 $4.2 $13.3 $11.32
Gross Profit $16.57 $32.77 $18.15 $20.46
Operating activities
Research & development $1.69 $1.37 $1.93 $2.37
Selling, general & administrative $26.94 $28.44 $29.62 $32.37
Total operating expenses $36.32 $37.5 $39.24 $42.43
Operating income -$19.76 -$4.73 -$21.09 -$21.97
Income from continuing operations
EBIT -$16.7 -$11.56 -$23.01 -$15.69
Income tax expense $0.26 $1.67 -$3.1 -$0.53
Interest expense $7.56 $7.34 $7.17 $7.71
Net income
Net income -$24.52 -$20.57 -$27.07 -$22.86
Income (for common shares) -$24.52 -$20.57 -$27.07 -$22.86
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $129.07 $152.97 $192.41 $471.43
Cost of revenue $40.79 $33.51 $34.85 $99.31
Gross Profit $88.28 $119.45 $157.56 $372.12
Operating activities
Research & development $10.42 $23.01 $60.08 $106.38
Selling, general & administrative $124.4 $152.58 $192.85 $172.25
Total operating expenses $165.58 $268.38 $556.13 $278.62
Operating income -$77.3 -$148.92 -$398.57 $93.5
Income from continuing operations
EBIT -$79.04 -$77.09 -$252.38 $42.02
Income tax expense -$5.12 -$8.07 -$1.28 -$13.26
Interest expense $30.04 $30.57 $21.87 $21.6
Net income
Net income -$103.95 -$99.59 -$272.97 $33.68
Income (for common shares) -$103.95 -$99.59 -$272.97 $33.68
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Net income -$24.52 -$20.57 -$27.07 -$22.86
Operating activities
Depreciation $8.53 $8.47 $8.32 $8.63
Business acquisitions & disposals
Stock-based compensation $0.48 $0.48 $0.85 $0.95
Total cash flows from operations -$13.64 $3.24 -$9.01 -$8.69
Investing activities
Capital expenditures -$0.04 -$0 -$0.14
Investments $73.97
Total cash flows from investing -$0.04 $73.97 -$0.14
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$73.97 -$69
Total cash flows from financing -$73.97 -$69
Effect of exchange rate -$0.09 $0.06 -$0.06 $0.38
Change in cash and equivalents -$13.77 $3.3 -$9.08 -$77.44
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$103.95 -$99.59 -$272.97 $33.68
Operating activities
Depreciation $33.95 $41.3 $34.57 $11.48
Business acquisitions & disposals $7.88
Stock-based compensation $3 $8.1 $14.25 $21.25
Total cash flows from operations -$41.35 -$61.01 -$128.17 $150.79
Investing activities
Capital expenditures -$0.17 -$4.39 -$90.43 -$33.33
Investments $73.97 $63.75 $89.92 -$150.83
Total cash flows from investing $73.78 $59.36 -$0.51 -$176.87
Financing activities
Dividends paid
Sale and purchase of stock -$0.07 $13.45
Net borrowings -$69.66 -$1.67 -$60.48 -$0.66
Total cash flows from financing -$69.66 -$1.67 -$60.55 $12.8
Effect of exchange rate -$0.45 $1.02 $0.06 -$0.41
Change in cash and equivalents -$37.67 -$2.3 -$189.16 -$13.69
Fundamentals
Market cap $6.37M
Enterprise value $148.26M
Shares outstanding 13.28M
Revenue $122.74M
EBITDA -$33.00M
EBIT -$66.96M
Net Income -$95.02M
Revenue Q/Q -21.93%
Revenue Y/Y -20.16%
P/E ratio -0.07
EV/Sales 1.21
EV/EBITDA -4.49
EV/EBIT -2.21
P/S ratio 0.05
P/B ratio 0.05
Book/Share 9.65
Cash/Share 3.87
EPS -$7.16
ROA -20.69%
ROE -59.99%
Debt/Equity 2.01
Net debt/EBITDA -7.43
Current ratio 1.75
Quick ratio 1.43